A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.
暂无分享,去创建一个
Matthias Kretzler | Viji Nair | Kevin V Lemley | Jeffrey Hodgin | Wenjun Ju | W. Ju | V. Nair | J. Hodgin | M. Kretzler | R. Nelson | P. Nelson | K. Lemley | B. Godfrey | J. Harder | E. Weil | B. Yee | Peter J Nelson | Robert G Nelson | Claudiu V Komorowsky | E Jennifer Weil | Berne Yee | Jennifer L Harder | Bradley Godfrey | Carine M Boustany-Kari | Margrit Schwarz | C. M. Boustany-Kari | R. Nelson | Margrit Schwarz | Peter J. Nelson | Claudiu V. Komorowsky | Carine M. Boustany-Kari | Claudiu Komorowsky | Peter J. Nelson | Robert G Nelson | Robert G. Nelson
[1] K. Shedden,et al. NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. , 2010, Journal of the American Society of Nephrology : JASN.
[2] Benjamin J. Keller,et al. Integrative biology identifies shared transcriptional networks in CKD. , 2014, Journal of the American Society of Nephrology : JASN.
[3] T. Meyer,et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. , 2000, Kidney international.
[4] P. Bennett,et al. Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. , 2000, Journal of the American Society of Nephrology : JASN.
[5] C. Cohen,et al. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. , 2002, Kidney international.
[6] R. Hanson,et al. Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] T. Weinstein,et al. Glomerular hemodynamics in severe obesity. , 2000, American journal of physiology. Renal physiology.
[8] Felix Eichinger,et al. Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.
[9] J. Patel,et al. Identification of Cross-Species Shared Transcriptional Networks of Diabetic Nephropathy in Human and Mouse Glomeruli , 2012, Diabetes.
[10] Quan Dong Nguyen,et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.
[11] M. Rastaldi,et al. Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy , 2009, Diabetes.
[12] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[13] R. Schmieder,et al. How should renal hemodynamic data be indexed in obesity? , 1995, Journal of the American Society of Nephrology.
[14] K. Suszták,et al. Transcriptome Analysis of Human Diabetic Kidney Disease , 2011, Diabetes.
[15] B. Kasiske,et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] R. Hanson,et al. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes , 2013, Diabetes.
[17] Haifeng Guo,et al. US Renal Data System 2012 Annual Data Report. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] B. Zinman,et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. , 2011, Archives of internal medicine.
[19] M. Woodward,et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis , 2012, The Lancet.
[20] R. Radermecker,et al. Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] R. Bader,et al. Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. , 1980, Pathology, research and practice.
[22] E. Weibel. Practical methods for biological morphometry , 1979 .
[23] Jun Wada,et al. Innate immunity in diabetes and diabetic nephropathy , 2016, Nature Reviews Nephrology.
[24] Andrzej S Krolewski,et al. Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.
[25] Jinu Kim,et al. Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury. , 2014, Journal of the American Society of Nephrology : JASN.
[26] Alan B Leichtman,et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] Patrick J Heagerty,et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.
[28] A Bohle,et al. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. , 1991, Pathology, research and practice.
[29] Merlin C. Thomas,et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.
[30] P. Bennett,et al. Change in the Distribution of Albuminuria According to Estimated Glomerular Filtration Rate in Pima Indians With Type 2 Diabetes , 2009, Diabetes Care.
[31] H. Anders. Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.
[32] H. Anders,et al. Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] R. Olshen,et al. Modeling GFR trajectories in diabetic nephropathy. , 2005, American journal of physiology. Renal physiology.
[34] R. G. Miller,et al. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study , 2010, Diabetologia.
[35] A. Sanz,et al. Suppressors of cytokine signaling abrogate diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.
[36] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[37] K. Shedden,et al. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker , 2015, Science Translational Medicine.
[38] J. Bonventre. Can we target tubular damage to prevent renal function decline in diabetes? , 2012, Seminars in nephrology.
[39] Ping Zhang,et al. The Lifetime Cost of Diabetes and Its Implications for Diabetes Prevention , 2014, Diabetes Care.
[40] W. Neuhofer. Role of NFAT5 in Inflammatory Disorders Associated with Osmotic Stress , 2010, Current genomics.
[41] M. Kretzler,et al. JAK inhibition in the treatment of diabetic kidney disease , 2016, Diabetologia.
[42] R. Nelson,et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy , 2012, Kidney international.
[43] K. Nath,et al. Tubulointerstitial changes as a major determinant in the progression of renal damage. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[44] A. Levey,et al. Obesity, glomerular hyperfiltration, and the surface area correction. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] J. Navarro-González,et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy , 2011, Nature Reviews Nephrology.